KELSEY O'MARA: Open Payments
NPI 1376871426 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 16 payments from 7 companies in 2025. Trend: 2023 $1,184 · 2024 $1,641 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $189 |
| Averitas Pharma Inc. | 2 | $178 |
| Boston Scientific Corporation | 1 | $173 |
| SI-BONE, INC. | 5 | $128 |
| ABBVIE INC. | 2 | $51 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Curonix LLC | 1 | $16 |
Products named: QUTENZA, Intracept, PROCLAIM, ETERNA, JOURNAVX, BOTOX, UBRELVY, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A.
Industry payments across KY — which companies pay providers there.
